NFKB1 and Cognitive impairment: Similarly, it had been reported that aloin treatment inhibited the activation of NF-κB signaling in lipopolysaccharide-induced acute lung injury, IL-1 beta-stimulated chondrocytes, and D-galactose-induced cognitive impairment and inflammation [37, 38, 44].